Gwen Melincoff
Director/Board Member bei GAIN THERAPEUTICS, INC.
Vermögen: 575 610 $ am 31.03.2024
Ursprung des Netzwerks ersten Grades von Gwen Melincoff
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA
31
| Subsidiary | Pharmaceuticals: Major | 31 |
| Public Company | Pharmaceuticals: Major | 28 | |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA.
19
| Subsidiary | Biotechnology | 19 |
| Public Company | Pharmaceuticals: Major | 19 | |
| Public Company | Pharmaceuticals: Major | 18 | |
| Subsidiary | Pharmaceuticals: Major | 16 | |
| Public Company | Biotechnology | 15 | |
| Public Company | Medical Specialties | 13 | |
12
| Public Company | Biotechnology | 12 |
BTG International, Inc.
 BTG International, Inc. Investment ManagersFinance BTG International Inc. (BTG International) is a venture capital subsidiary of BTG Ltd founded in 1981. The firm is headquartered in West Conshohocken, Pennsylvania.
1
| Subsidiary | Investment Managers | 1 |
Vodia Capital LLC
 Vodia Capital LLC Investment ManagersFinance Part of Robertson Stephens Wealth Management LLC, Vodia Capital LLC provides investment advisory services. The private company is based in Concord, MA. The company was founded by David B. Matias. David B. Matias has been the CEO since incorporation. Vodia Capital was acquired by Robertson Stephens Wealth Management LLC on December 13, 2022.
1
| Subsidiary | Investment Managers | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Gwen Melincoff
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Sales & Marketing | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Sales & Marketing Sales & Marketing | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Consultant / Advisor | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer General Counsel Director of Finance/CFO | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Chairman Director/Board Member Chief Executive Officer | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
| XENOPORT, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
| SOL-GEL TECHNOLOGIES LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Doctorate Degree Masters Business Admin Graduate Degree | |
| Technion-Israel Institute of Technology | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| The Hebrew University of Jerusalem | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Masters Business Admin Graduate Degree Masters Business Admin | |
| VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member President | |
| Weizmann Institute of Science | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| MEDIWOUND LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| The College of Management Academic Studies | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Protalix Ltd. | Founder Chairman Director/Board Member Director/Board Member | ||
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Zavante Therapeutics, Inc.
 Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zavante Therapeutics, Inc. manufactures pharmaceutical products. Its product ZOLYD is an investigational, first-in-class epoxide antibiotic with a spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. The company was founded by Cam L. Garner, Evelyn Ellis-Grosse and Theodore R. Schroeder in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Founder | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
GT Gain Therapeutics SA
 GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chairman Corporate Officer/Principal | |
| ADYNXX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| NEUBASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member |
Statistik
International
| Vereinigte Staaten | 38 |
| Israel | 11 |
| Schweiz | 3 |
| Norwegen | 2 |
Sektoral
| Health Technology | 38 |
| Consumer Services | 10 |
| Finance | 4 |
Operativ
| Director/Board Member | 678 |
| Corporate Officer/Principal | 212 |
| Independent Dir/Board Member | 204 |
| Chairman | 186 |
| Chief Executive Officer | 156 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Zeev Bronfeld | 46 |
| Eckard Weber | 46 |
| Pierre Legault | 45 |
| Ernest Mario | 44 |
| Patrick Heron | 42 |
| John Freund | 37 |
| Eliot Forster | 35 |
| Mahendra Shah | 34 |
| Jan Hendrik Egberts | 33 |
| Ambrose Bailey | 32 |
| Khalid Islam | 29 |
| Aharon Schwartz | 29 |
| Bruce Peacock | 28 |
| Dov Goldstein | 28 |
| Hans-Peter Hasler | 28 |
- Börse
- Insiders
- Gwen Melincoff
- Unternehmensverbindungen
